127 related articles for article (PubMed ID: 32492752)
1. KRAS mutations in brown tumor of the jaws in hyperparathyroidism.
Guimarães LM; Gomes IP; Pereira TDSF; de Andrade BAB; Romañach MJ; de Lacerda JCT; Pontes HAR; Brennan PA; Rahimi S; Carlos R; Mosqueda-Taylor A; Bologna-Molina R; Passador-Santos F; Gomez RS; Gomes CC
J Oral Pathol Med; 2020 Sep; 49(8):796-802. PubMed ID: 32492752
[TBL] [Abstract][Full Text] [Related]
2. KRAS mutations in implant-associated peripheral giant cell granuloma.
Martins-Chaves RR; Guimarães LM; Pereira TDSF; Pereira NB; Chrcanovic BR; Fonseca FP; Lafuente-Ibáñez de Mendoza I; Aguirre-Urizar JM; Gomes CC; Gomez RS
Oral Dis; 2020 Mar; 26(2):334-340. PubMed ID: 31758745
[TBL] [Abstract][Full Text] [Related]
3. Brown Tumors Belong to the Spectrum of KRAS -driven Neoplasms.
Turek D; Haefliger S; Ameline B; Alborelli I; Calgua B; Hartmann W; Harder D; Flanagan AM; Amary F; Baumhoer D
Am J Surg Pathol; 2022 Nov; 46(11):1577-1582. PubMed ID: 36040039
[TBL] [Abstract][Full Text] [Related]
4. Integrated proteomics, phosphoproteomics and metabolomics analyses reveal similarities among giant cell granulomas of the jaws with different genetic mutations.
Vitório JG; Duarte-Andrade FF; Pereira TDSF; Melo-Braga MN; Canuto GAB; Macedo AN; Lebron YAR; Moreira VR; Felicori LF; Lange LC; Santos LVS; Larsen MR; Gomes CC; Gomez RS
J Oral Pathol Med; 2022 Aug; 51(7):666-673. PubMed ID: 35706152
[TBL] [Abstract][Full Text] [Related]
5. Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next-generation sequencing.
Gomes CC; Diniz MG; Bastos VC; Bernardes VF; Gomez RS
J Pathol; 2020 Feb; 250(2):126-133. PubMed ID: 31705763
[TBL] [Abstract][Full Text] [Related]
6. A new TRPV4 mutation in a case of multiple central giant cell granulomas of the jaws.
Guimarães LM; Martins-Chaves RR; Chabot PQ; Schreuder WH; de Castro WH; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Mar; 135(3):e68-e73. PubMed ID: 36529675
[TBL] [Abstract][Full Text] [Related]
7. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw.
Gomes CC; Gayden T; Bajic A; Harraz OF; Pratt J; Nikbakht H; Bareke E; Diniz MG; Castro WH; St-Onge P; Sinnett D; Han H; Rivera B; Mikael LG; De Jay N; Kleinman CL; Valera ET; Bassenden AV; Berghuis AM; Majewski J; Nelson MT; Gomez RS; Jabado N
Nat Commun; 2018 Nov; 9(1):4572. PubMed ID: 30385747
[TBL] [Abstract][Full Text] [Related]
8. Multiple versus solitary giant cell lesions of the jaw: Similar or distinct entities?
Schreuder WH; van der Wal JE; de Lange J; van den Berg H
Bone; 2021 Aug; 149():115935. PubMed ID: 33771761
[TBL] [Abstract][Full Text] [Related]
9. KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features.
Coura BP; Bernardes VF; de Sousa SF; França JA; Pereira NB; Pontes HAR; Batista AC; da Cruz Perez DE; Albuquerque Junior RLC; de Souza LB; Martins MD; Diniz MG; Gomez RS; Gomes CC
Mod Pathol; 2019 Jun; 32(6):799-806. PubMed ID: 30643167
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
11. Detection of MAPK/ERK pathway proteins and KRAS mutations in adenomatoid odontogenic tumors.
Bologna-Molina R; Ogawa I; Mosqueda-Taylor A; Takata T; Sánchez-Romero C; Villarroel-Dorrego M; Takeda Y; Mikami T
Oral Dis; 2019 Mar; 25(2):481-487. PubMed ID: 30294831
[TBL] [Abstract][Full Text] [Related]
12. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome.
Jackson CE; Norum RA; Boyd SB; Talpos GB; Wilson SD; Taggart RT; Mallette LE
Surgery; 1990 Dec; 108(6):1006-12; discussion 1012-3. PubMed ID: 2123361
[TBL] [Abstract][Full Text] [Related]
14. Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey.
Park JT; Johnson N; Liu S; Levesque M; Wang YJ; Ho H; Huso D; Maitra A; Parsons MJ; Prescott JD; Leach SD
Oncogene; 2015 May; 34(21):2801-6. PubMed ID: 25065594
[TBL] [Abstract][Full Text] [Related]
15. KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells.
Leiser D; Medová M; Mikami K; Nisa L; Stroka D; Blaukat A; Bladt F; Aebersold DM; Zimmer Y
Mol Oncol; 2015 Aug; 9(7):1434-46. PubMed ID: 25933688
[TBL] [Abstract][Full Text] [Related]
16. Localization of active, dually phosphorylated extracellular signal-regulated kinase 1 and 2 in colorectal cancer with or without activating BRAF and KRAS mutations.
Holck S; Bonde J; Pedersen H; Petersen AA; Chaube A; Nielsen HJ; Larsson LI
Hum Pathol; 2016 Aug; 54():37-46. PubMed ID: 27036313
[TBL] [Abstract][Full Text] [Related]
17. Mutation-Specific and Common Phosphotyrosine Signatures of
Tahir R; Renuse S; Udainiya S; Madugundu AK; Cutler JA; Nirujogi RS; Na CH; Xu Y; Wu X; Pandey A
J Proteome Res; 2021 Jan; 20(1):670-683. PubMed ID: 32986951
[No Abstract] [Full Text] [Related]
18. Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
Alamo P; Gallardo A; Di Nicolantonio F; Pavón MA; Casanova I; Trias M; Mangues MA; Lopez-Pousa A; Villaverde A; Vázquez E; Bardelli A; Céspedes MV; Mangues R
FASEB J; 2015 Feb; 29(2):464-76. PubMed ID: 25359494
[TBL] [Abstract][Full Text] [Related]
19. Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS
Kun EHS; Tsang YTM; Lin S; Pan S; Medapalli T; Malpica A; Richards JS; Gershenson DM; Wong KK
Sci Rep; 2020 Nov; 10(1):20678. PubMed ID: 33244099
[TBL] [Abstract][Full Text] [Related]
20. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Vetiska S; Bonilla X; Boudreau E; Jauhiainen S; Rezai Jahromi B; Khyzha N; DiStefano PV; Suutarinen S; Kiehl TR; Mendes Pereira V; Herman AM; Krings T; Andrade-Barazarte H; Tung T; Valiante T; Zadeh G; Tymianski M; Rauramaa T; Ylä-Herttuala S; Wythe JD; Antonarakis SE; Frösen J; Fish JE; Radovanovic I
N Engl J Med; 2018 Jan; 378(3):250-261. PubMed ID: 29298116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
